Studies with the Wld S mutant mouse have shown that axon and synapse pathology in several models of neurodegenerative diseases are mechanistically related to injury-induced axon degeneration (Wallerian degeneration). Crucially, an absence of SARM1 delays Wallerian degeneration as robustly as Wld S , but their relative capacities to confer long-term protection against related, non-injury axonopathy and/ or synaptopathy have not been directly compared. While Sarm1 deletion or Wld S can rescue perinatal lethality and widespread Wallerian-like axonopathy in young NMNAT2-deficient mice, we report that an absence of SARM1 enables these mice to survive into old age with no overt phenotype, whereas those rescued by Wld S invariantly develop a progressive neuromuscular defect in their hindlimbs from around 3 months of age. We therefore propose Sarm1 deletion as a more reliable tool than Wld S for investigating Wallerian-like mechanisms in disease models and suggest that SARM1 blockade may have greater therapeutic potential than WLD S -related strategies.
INTRODUCTION

Wld
S , a spontaneous mutant mouse allele encoding a fusion protein (WLD S ) with nicotinamide mononucleotide adenylyltransferase (NMNAT) activity, robustly delays injury-induced axon and synapse degeneration (Wallerian degeneration) by locally substituting for loss of the endogenous NMNAT2 isoform (Mack et al., 2001; Gilley and Coleman, 2010; Cohen et al., 2012; Conforti et al., 2014) . Wld S has been the tool of choice for investigating the molecular basis of axon pathology in animal models of neurodegenerative diseases and has revealed an involvement of Wallerian-like mechanisms in several cases (Conforti et al., 2014) . Key steps in this process are thus potential targets for intervention in patients. Sterile alpha and TIR motif-containing protein 1 (SARM1) acts downstream of NMNAT2 loss to promote axon degeneration (Osterloh et al., 2012; Gerdts et al., 2013; Gilley et al., 2015; Loreto et al., 2015; Walker et al., 2017) . Depletion of SARM1 is, to date, the only other manipulation that can delay Wallerian degeneration and related axon degeneration in mice as robustly as exogenous expression of WLD S or other NMNAT variants (Conforti et al., 2014) , but its effectiveness in maintaining the longterm health of axons and synapses in mouse models of axonopathy and/or synaptopathy has not yet been directly compared to Wld S . Such a comparison is needed to ascertain the relative usefulness of Sarm1 deletion in determining whether Wallerianlike mechanisms are involved in models of neurodegeneration and should be informative in terms of therapeutic strategies for those disorders.
An absence of NMNAT2 in mice causes widespread axon truncation during embryogenesis and perinatal lethality (Gilley et al., 2013) . Early rescue by Wld S (dose dependently) or by Sarm1 deletion has shown that outgrowth of NMNAT2-deficient axons stalls due to a Wallerian-like degenerative mechanism (Gilley et al., 2013 (Gilley et al., , 2015 . Reduced NMNAT2 levels have already been linked to tauopathy in mice and to decreased cognitive function in humans (Ljungberg et al., 2012; Ali et al., 2016) , but the severity of the phenotype in mice lacking NMNAT2 suggests a complete lack of the protein is unlikely to directly model any neurodegenerative conditions. Nevertheless, these mice represent a welldefined and robust system for comparing the longer-term protective effects of Wld S and Sarm1 deletion against a severe Wallerian-like axonopathy. While the survival of NMNAT2-deficient mice homozygous for either Wld S or a Sarm1 knockout allele up to 3 months of age with no overt problems initially suggested similarly robust rescue in each case (Gilley et al., 2013 (Gilley et al., , 2015 , we now report striking age-dependent differences between the two lines, which are likely to have important experimental and therapeutic implications. À/À mice, respectively) are born at the expected frequencies and are outwardly indistinguishable from NMNAT2-expressing littermates up to 3 months of age (Table S1 ) (Gilley et al., 2013 (Gilley et al., , 2015 . However, despite continued silencing of the trapped Nmnat2 alleles in each case (Figure S1A See also Movies S1, S2, S3, S4, S5, and S6, Table  S1 , and Figure S1 .
RESULTS
Locomotor Defects and Muscle Atrophy in
neous locomotion, but this progressively deteriorated, resulting in mice invariantly dragging their hindlimbs regularly during locomotion from around 6 months onward as a result of worsening paraparesis (Movies S1, S2, S3, and S4 Figure S1B ). A specific analysis of gastrocnemius muscle revealed evidence of some muscle fiber atrophy and slightly reduced muscle weight even at 10 weeks in Nmnat2 gtE/gtE ; Wld S/S mice, before the onset of overt locomotor dysfunction, but this had progressed to severe muscle fiber atrophy and loss of mass by 10 months ( Figures 1C and 1D ). In contrast, no muscle fiber atrophy or loss of mass was seen in Nmnat2 gtE/gtE ; Sarm1 À/À gastrocnemius up to 24 months ( Figures 1C-1E ).
Although Nmnat2 gtE/gtE ;Wld S/S mice did not lose body weight between 10 weeks and 10-12 months, they failed to gain weight as expected ( Figure S1C ). This presumably reflected loss of muscle mass in the hindlimb being broadly matched by normal weight gain in the upper torso and forelimbs, which appeared largely unaffected. In contrast, developmental weight gain in Nmnat2 gtE/gtE ;Sarm1 À/À mice was comparable to Sarm1 À/À controls up to 24 months ( Figure S1D ). gastrocnemius was found to be moderately reduced at 10 weeks, but consistent with the timing of gastrocnemius muscle fiber atrophy and weight loss in these mice, by 10 months, denervation was extensive, with only around 10% of endplates showing normal innervation (Figures 2A and 2B ). We also investigated motor endplate occupancy in a more distal hindlimb muscle, flexor digitorum brevis (FDB), at 10 months. Although denervation was also evident in this muscle ( Figure 3A) , it was less severe than in gastrocnemius at the same age. Clear regional variation in the pattern of endplate occupancy was seen in FDB, with discrete zones of normal innervation being found adjacent to zones of complete denervation (Figures 3B and 3C) . Isometric tension recordings indicated that this distinctive pattern of NMJ innervation reflects discrete loss of entire motor units (Figures 3D and 3E) , with apparently normal function of remaining motor units ( Figure S2 ).
Neuromuscular Denervation in
In contrast, and consistent with the lack of locomotor problems, no significant endplate denervation and/or motor unit loss was evident in either gastrocnemius or FDB muscles from 10-month-old Nmnat2 gtE/gtE ;Sarm1 À/À mice (Figures 2, 3A, 3D, 3E, and S2) and innervation remained comparable to Sarm1 À/À controls at 24 months, despite modest age-dependent denervation in both ( Figure 2A ). Wld S/S and Sarm1 À/À mice both performed maximally in locomotor tests, and neither showed signs of neuromuscular denervation at the ages studied. Although a direct comparison with wild-type mice will be needed to establish whether more subtle differences in motor function exist in either line, our data suggest that both have broadly normal neuromuscular function. The defect in Nmnat2 gtE/gtE ;Wld S/S mice thus appears to be specific to a declining inability of WLD S to counter the lack of NMNAT2 in older mice, rather than other intrinsic differences.
No Loss of Myelinated Tibial Nerve Axons in Either
Despite progressive denervation of motor endplates in hindlimb muscles from Nmnat2 gtE/gtE ;Wld S/S mice, no concurrent loss of myelinated axons was seen in the tibial nerve ( Figure 4A ) and axons remained morphologically normal ( Figure 4B ). A gross assessment revealed that most hindlimb muscles became extensively atrophied in these mice ( Figure S1B ), so significantly reduced numbers of axons would have been expected, even in a mixed nerve such as this, if motor axon loss was the underlying cause. The age-dependent neuromuscular denervation in Nmnat2 gtE/gtE ;Wld S/S muscles thus appears to result from selective loss of the distal ends of motor axons and/or their terminals. This mirrors the age-dependent loss of protection of synapses at NMJs after axotomy in homozygous Wld S mice, despite continued protection of the main body of the transected axon (Gillingwater et al., 2002) .
Counts of myelinated axons in Nmnat2 gtE/gtE ;Sarm1 À/À tibial nerves remained comparable to those of Sarm1 À/À controls, even up to 24 months ( Figure 4A ), with no age-related axon loss in either group up to this age. We also found no significant axon loss in a separate cohort of wild-type mice (on a related background) up to 24 months (1,514 ± 22 myelinated axons at 1.5 months, compared to 1,473 ± 40 at 24 months). This contrasts a previous study that reported significant loss of myelinated tibial nerve axons by 24 months in wild-type mice (Valdez et al., 2010) , although this could simply reflect strain differences.
DISCUSSION
To date, Wld S has been the preferred tool for assessing the involvement of Wallerian-like axon and synapse degeneration in rodent models of neurodegeneration (Conforti et al., 2014 , which is required for protection (Beirowski et al., 2009; Cohen et al., 2012) , is likely to be subject to a variety of influences, whereas protection conferred by an absence of SARM1 will be invariant. Global expression of WLD S in homozygous Wld S mice does not diminish significantly with age up to 12 months (Gillingwater et al., 2002 Figure 2A ). showing progressive, discrete recruitment of motor units (incremental steps in twitch tension) during continuously graded stimulation of the nerve. (E) Motor unit numbers in FDB muscles from 10-month-old male mice of the indicated genotypes (n = 4 or 6 muscles from 2 or 3 mice as shown). Individual values and means ± SEM are plotted (NS, not significant [p > 0.99] or ***p < 0.001 in one-way ANOVA with Tukey's multiple comparisons, selected comparisons). See also Figure S2 .
WLD
S -mediated protection than those relating to axon length (FDB being more distal). These considerations will similarly apply to the age-dependent loss of protection of motor axon terminals after axotomy (and the resulting NMNAT2 loss) in homozygous Wld S mice (Gillingwater et al., 2002) . Annulospiral (sensory) nerve endings in the muscle remained protected in older mice in that context, suggesting a motor-specific defect (Oyebode et al., 2012 rescuing symptoms in models of other types of neurodegenerative disease, not just those with early neuromuscular symptoms. If the disease-causing defect in a given model additionally reduces the activity or concentration of WLD S within axons or synapses in some way, then its protective capacity might be diminished. This could apply to disorders of axonal transport, protein synthesis, or protein turnover, among others. Our findings have therapeutic implications for human disorders. Specifically, they suggest that strategies directed at blockade of SARM1 function have the potential to be more effective than WLD S -related therapies in neuromuscular synaptopathies and potentially in a broader group of neurodegenerative disorders. In addition, the remarkable survival and health of Nmnat2 gtE/gtE ;Sarm1 À/À mice into old age suggests that even long-term therapeutic interventions based on blocking SARM1 function might be both effective and well tolerated by patients. This study confirms SARM1 as a key regulator of degeneration caused by a NMNAT2 deficiency. Sarm1 deletion appears to block this process indefinitely without affecting long-term survival, despite the predicted substantial reduction in nicotinamide adenine dinucleotide (NAD)-synthesizing capacity (Gilley et al., 2015) . SARM1 has been shown to possess NADase activity that promotes injury-induced axon or synapse degeneration and can be inhibited by NMNAT activity (Gerdts et al., 2015; Sasaki et al., 2016; Essuman et al., 2017) . Therefore, a model in which survival depends on NMNAT-dependent NAD production balancing NAD consumption, including any resulting from constitutive SARM1 NADase activity, is attractively simple. However, NAD consumption in uninjured Sarm1 À/À axons has been shown to be comparable to wild-type consumption, suggesting that SARM1 NADase activity under normal conditions is minimal (Sasaki et al., 2016) . Instead, a situation in which a loss of NMNAT activity results in the upregulation of SARM1 NADase activity via intermediate signals and/or interactions to trigger degeneration is more consistent with current findings (Sasaki et al., 2016; Di Stefano et al., 2017) . Finally, the similarity between the progressive phenotype in Nmnat2 gtE/gtE ;Wld S/S mice and some mouse models of ALS is intriguing. While there is, as yet, no established link between NMNAT2 and ALS, the SARM1 locus has been associated with sporadic ALS (Fogh et al., 2014) S , and Sarm1 knockout alleles was performed as described previously (Gilley et al., 2013 (Gilley et al., , 2015 . Littermates were used where possible. The ages and genders of mice used in individual experiments are described in the figure legends. Accelerating Rotarod Task Locomotor performance was tested on an accelerating Rotarod (Ugo Basile, Model 7650, Varese, Italy). Mice were familiarized with the apparatus (two 5 min runs at 10 rpm) one day before testing. At each test age, mice performed three 5 min trials (3 to 30 rpm) separated by 30 min rests. Latency to fall (max 300 s) was recorded. Only involuntary falls were scored. Mice dismounting voluntarily were placed back onto the apparatus once, but the run was excluded from the analysis if repeated. Best trial performance was used for statistical analyses.
RT-PCR
H&E Staining
Transverse cryosections of gastrocnemius muscles snap frozen in liquid nitrogen-chilled isopentane (8 mm thickness) or fixed in 4% paraformaldehyde (20 mm thickness) were stained with H&E as previously described (Gilley et al., 2013) . Images were captured using a MicroPublisher camera (QImaging) on an Olympus BX50 microscope (203 objective). Staining of snap-frozen muscle sections was optimal for visualization of muscle structure without the artifactual muscle fiber separation seen on fixed sections.
NMJ Innervation
Innervation of NMJs in gastrocnemius and FDB muscles was assessed by immunofluorescent staining. Staining was performed essentially as described previously (Krieger et al., 2013) on whole-mount muscles or longitudinal cryosections (60 mm thickness). Confocal z stack series were acquired using Olympus FV1000 or Leica SPE scanning laser confocal microscopes (203 or 403 objectives). Multiple z stack series were acquired for each muscle, and z projections were generated for analysis. Endplate occupancy was determined by assessing the extent of overlap or direct abuttal of bIII-tubulin staining (axon terminal) with a-bungarotoxin staining (endplate). Endplates were scored as denervated when essentially none of the endplate (less than $5%) was deemed to be occupied by the axon terminal, fully innervated with complete (greater than $95%) occupancy, and partially innervated with intermediate occupancy (observer determined, scored blind). Original z stack series were examined to exclude chance overlay of proximal axon segments and endplates in non-adjacent focal planes.
Isometric Muscle Tension Recordings
Force measurements for FDB muscle were made from FDB muscle-tibial nerve preparations as described previously (Beirowski et al., 2009) , except that the proximal tendon was connected to a MLT0202 (0-25 g) isometric force transducer (AD Instruments, Oxford, UK) and the tibial nerve was stimulated using 0.1-0.2 ms pulses of up to 10 V using a Digitimer DS2 isolated stimulator (Digitimer, Welwyn Garden City, UK) triggered via a Powerlab 26T interface. Tension responses were digitized at 1 kHz using Chart 7 or Scope 4 software (all ADInstruments).
Counts of Myelinated Tibial Nerve Axons
Transverse sections (20 mm) of fixed calf (from mid-way between knee and ankle) were stained with FluoroMyelin red according to the manufacturer's instructions (Life Technologies). Images of tibial nerves were captured on an Olympus FV1000 point scanning confocal microscope imaging system (403 objective). Axon counts (inferred from numbers of myelin sheaths) were performed blind using the multi-point selection tool in ImageJ.
Statistical Analysis
Appropriate statistical testing of data was performed using Prism (GraphPad Software, La Jolla, USA). Tests are described in the figure legends. A p value < 0.05 was considered significant.
DATA AND SOFTWARE AVAILABILITY
Source data for graphs can be found in the Maximum tetanic force of FDB muscles from10-month-old male mice of the genotypes listed. Data are mean ±SEM (n = 6 muscles from three mice, except for n = 4 muscles from two Sarm1 -/-mice). Nmnat2 gtE/gtE ;Wld S/S force is noticeably reduced compared to the other genotypes due to reduced numbers of motor units (Fig. 3E) , although substantial intragenotype variation means that group sizes are not sufficient for statistical significance (one-way ANOVA, p > 0.05). (C) Correlation between (reduced) numbers of motor units in Nmnat2 gtE/gtE ;Wld S/S FDB muscle explants and maximum tetanic force. Spearman correlation r = 0.986 (p = 0.0056). This suggests that, although different numbers of motor units remain in individual 10-month-old Nmnat2 gtE/gtE ;Wld S/S FDB muscles, those that are present are similar in size. (D) Representative fatigue profiles of FDB muscle explants of the four genotypes studied (as indicated) elicited by 50 Hz tetanic stimulation for 3 s, at intervals of 5s (gaps between each tetanus were clipped). (E) Fatigue resistance of FDB muscle explants for 10-month-old mice of the genotypes listed. Individual values with means ±SEM are plotted (same groups sizes as in B). The index of fatigue resistance is the stimulus number that produced a tetanic force equal to 50% of the initial force. 
